无进展生存期（pfs）、无病生存期（dfs）、无事件生存 (efs) 三者为类似意义的终点。 无病生存期（DFS）主要评价疾病复发 ，多用于评价手术治疗或 ...

PFS和OS双终点阳性：PFS主要分析和OS最终分析显示，与索拉非尼相比，特瑞普利单抗联合贝伐珠单抗可显著延长PFS和OS，两组中位PFS分别为5.8 vs. 4.0个 ...

康宁杰瑞制药此前公布，公司与 石药集团 （01093）附属上海津曼特合作开发的kn026（kn026- 001）联合化疗二线及以上治疗her2阳性gc（包括gej）的ii/iii期 ...

Table 2. Costs associated with vaccination using multidose vials and prefilled syringes in 2009 in the USA. Resources for 1000 doses MDVs ...

Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...

The PFS delivers the same drug as the currently available 6.0 mg Vabysmo vials in an alternative, ready-to-use format.

Faricimab was first approved by the FDA in its vial form in 2022. 2 The 2022 approval was based on the TENAYA and LUCERNE studies that were identical, randomized, multicenter, double-masked phase ...